View of Co-expression of BCL2 and C-MYC as a Potential Predictive Factor of Survival in Diffuse Large B Cell Lymphoma with Rituximab-Based Chemotherapy

Return to Article Details Co-expression of BCL2 and C-MYC as a Potential Predictive Factor of Survival in Diffuse Large B Cell Lymphoma with Rituximab-Based Chemotherapy Download Download PDF